Intuitive Surgical, Inc. $ISRG Shares Sold by Mirova US LLC

Mirova US LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 548,599 shares of the medical equipment provider’s stock after selling 19,524 shares during the quarter. Intuitive Surgical makes up 2.5% of Mirova US LLC’s investment portfolio, making the stock its 17th biggest position. Mirova US LLC’s holdings in Intuitive Surgical were worth $245,350,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Tobam lifted its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $27,000. 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth $30,000. Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth $30,000. Finally, Riggs Asset Managment Co. Inc. raised its holdings in Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 32 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 28,800 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 114,007 shares of company stock worth $63,533,844 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $575.40 on Tuesday. The firm has a market capitalization of $206.27 billion, a P/E ratio of 76.11, a P/E/G ratio of 5.28 and a beta of 1.68. The business has a 50 day simple moving average of $557.87 and a 200 day simple moving average of $507.44. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. BTIG Research boosted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada increased their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Piper Sandler boosted their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $611.08.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.